Predict your next investment

HEALTHCARE | Drug Development
poxelpharma.com

See what CB Insights has to offer

Business Relationships

7

Service Providers

3

Poxel Service Providers

3 Service Providers

Poxel has 3 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Subscribe to see more

Subscribe to see more

Provider Type

Counsel

Subscribe to see more

Subscribe to see more

Service Type

General Counsel

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Poxel Partners & Customers

7 Partners and customers

Poxel has 7 strategic partners and customers. Poxel recently partnered with Sumitomo Dainippon Pharma on April 4, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

4/21/2021

Partner

Sumitomo Dainippon Pharma

Japan

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021

Further , having regained Imeglimin rights from Metavant in the US , Europe and other countries not covered by our agreement with Sumitomo Dainippon Pharma , we are pursuing various opportunities to advance its development including partnering activities , '' commented Thomas Kuhn , CEO of Poxel .

9

8/30/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

2/12/2018

Licensee

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

2/12/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

10/30/2017

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

4/21/2021

8/30/2018

2/12/2018

2/12/2018

10/30/2017

Type

Partner

Partner

Licensee

Partner

Partner

Business Partner

Sumitomo Dainippon Pharma

Country

Japan

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

News Snippet

Poxel Provides Corporate Update and Reports Cash and Revenue for the First Quarter 2021

Further , having regained Imeglimin rights from Metavant in the US , Europe and other countries not covered by our agreement with Sumitomo Dainippon Pharma , we are pursuing various opportunities to advance its development including partnering activities , '' commented Thomas Kuhn , CEO of Poxel .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

9

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.